A special report by Tim Sandle.
A New Jersey compounding pharmacy has temporarily shut down its operations after Connecticut hospital officials reported finding visible mold in bags of an injection drug.
The U.S. Food and Drug Administration (FDA) has announced that Med Prep Consulting, Inc. is recalling all lots of all products compounded at its facility, due to lack of sterility assurance (see the end of this article for a list of the products being recalled). The move followed a voluntary consent order enacted Friday that will remain in effect until at least March 22.
The level of recall is to the user: regional hospital pharmacies and related departments, and physician’s office practices. The recall resulted from the pharmacy being notified by a Connecticut hospital that it observed visible particulate contaminants in 50 ml bags of MAGNESIUM SULFATE 2GM IN DEXTROSE 5% IN WATER, 50ML FOR INJECTION intravenous solution, confirmed to be mold.
Med Prep is a specialty intravenous I.V. pharmacy licensed by the State of New Jersey offering sterile compounding services. In operation since 1994. There was no word of the recall via a search of the company web site.
This incident follows on from the fungal contamination found in three lots of medication used for epidural steroid injections, which was packaged and marketed by the New England Compounding Center (NECC), a compounding pharmacy in Framingham, Massachusetts.
Compounding pharmacies are authorized, in the U.S., to combine, mix or alter ingredients to create specific formulations of drugs to meet the specific needs of individual patients, and only in response to individual prescriptions.
There is debate among governments and regulators about which agency has primary oversight of compounding pharmacy. The FDA says it has less power to overseas compounding pharmacies than it does traditional manufacturers of pharmaceuticals. State governments have clung to the power to regulate pharmacies of all kinds.
Other recent compounding pharmacy issues, where there have been contamination concerns, are, as noted by the New York Times and USA Today:
a) In August 2011, the FDA reported that repackaged injections of Avastin (bevacizumab) caused serious eye infections in the Miami, Florida area. A pharmacy had repackaged the Avastin from single-use vials into multiple single-use syringes, distributing them to multiple eye clinics, and infecting at least 12 patients. Some patients lost the remaining vision in the eye being treated.
b) From November 2011 to April 2012, 33 eye-surgery patients in seven states suffered a rare fungal eye infection tied to injectable drug products made by a compounding pharmacy in Ocala, Florida. Most of those patients suffered partial to severe vision loss.
c) In November 13 2012, it was reported that manufacturing problems were found at Ameridose, a Massachusetts company that makes injectable drugs.
Here is the list of all of Med Prep Consulting's products, all of which are being recalled:
Acetylcystiene vials
Alteplase syringe
Atropine syringe
Avastin syringe
Aztreonam syringe
Bacitracin vials
Bupivacaine Bag
Bupivacaine Syringe
Bupivacaine OnQ Pump
Calcium Gluconate Bag
Calcium Gluconate syringe
Cefazolin syringe
Cefazolin Bag
Cefepime syringe
Cefepime Bag
Cefotaxime syringe
Cefotetan syringe
Cefoxitin syringe
Ceftazidime syringe
Ceftazidime Bag
Ceftriaxone syringe
Ceftriaxone Bag
Cefuroxime syringe
Cefuroxime Bag
Clindamycin syringe
Darboepoetin (Aranesp) syringe
Dexamethasone Bag
Diltiazem Bag
Dobutamine Bag
Dobutamine syringe
Ephedrine syringes
Epinephrine Bag
Epinephrine Bag
Epinephrine syringe
Epoetin Alfa syringe
Esmolol syringes
Famotidine syringe
Fentanyl Citrate Bag
Fentanyl Citrate with Bupivacaine HCL Bag
Gentamicin syringe
Gentamicin Bag
Glycopyrrolate syringes
Granisetron syringe
Hectoral syringe
Heparin syringe
Heparin bag
Hydromorphone syringe
Hydromorphone Bag
Hydromorphone PCA syringe
LET Gel syringe
LET Soln syringe
Leukine syringe
Magnesium Sulfate bag
Meperidine Bag
Midazolam Bag
Midazolam syringe
Morphine Sulfate Bag
Morphine Sulfate syringe
Norepinephrine bag
Norepinephrine Syringe
Ondansetron Bag
Ondansetron syringe
Oxacillin syringe
Oxacillin Bag
Oxytocin bag
Palanosetron (Aloxi) syringe
Penicillin syringe
Penicillin Bag
Phenylephrine Bags
Phenylephrine syringes
Potassium Chloride Bag
Potassium Phosphate l bag
Ranitidine syringe
Rituxan syringe
Ropivacaine Bag
Ropivacaine OnQ Pump
Sodium Citrate syringe
Sodium Phosphate bag
Succinylcholine syringes
Sufentanil with Bupivacaine Bag
Timentin syringe
Tobramycin syringe
Zometa syringe
Posted by Tim Sandle
This incident follows on from the fungal contamination found in three lots of medication used for epidural steroid injections, which was packaged and marketed by the New England Compounding Center (NECC), a compounding pharmacy in Framingham, Massachusetts.
Compounding pharmacies are authorized, in the U.S., to combine, mix or alter ingredients to create specific formulations of drugs to meet the specific needs of individual patients, and only in response to individual prescriptions.
There is debate among governments and regulators about which agency has primary oversight of compounding pharmacy. The FDA says it has less power to overseas compounding pharmacies than it does traditional manufacturers of pharmaceuticals. State governments have clung to the power to regulate pharmacies of all kinds.
Other recent compounding pharmacy issues, where there have been contamination concerns, are, as noted by the New York Times and USA Today:
a) In August 2011, the FDA reported that repackaged injections of Avastin (bevacizumab) caused serious eye infections in the Miami, Florida area. A pharmacy had repackaged the Avastin from single-use vials into multiple single-use syringes, distributing them to multiple eye clinics, and infecting at least 12 patients. Some patients lost the remaining vision in the eye being treated.
b) From November 2011 to April 2012, 33 eye-surgery patients in seven states suffered a rare fungal eye infection tied to injectable drug products made by a compounding pharmacy in Ocala, Florida. Most of those patients suffered partial to severe vision loss.
c) In November 13 2012, it was reported that manufacturing problems were found at Ameridose, a Massachusetts company that makes injectable drugs.
Here is the list of all of Med Prep Consulting's products, all of which are being recalled:
Acetylcystiene vials
Alteplase syringe
Atropine syringe
Avastin syringe
Aztreonam syringe
Bacitracin vials
Bupivacaine Bag
Bupivacaine Syringe
Bupivacaine OnQ Pump
Calcium Gluconate Bag
Calcium Gluconate syringe
Cefazolin syringe
Cefazolin Bag
Cefepime syringe
Cefepime Bag
Cefotaxime syringe
Cefotetan syringe
Cefoxitin syringe
Ceftazidime syringe
Ceftazidime Bag
Ceftriaxone syringe
Ceftriaxone Bag
Cefuroxime syringe
Cefuroxime Bag
Clindamycin syringe
Darboepoetin (Aranesp) syringe
Dexamethasone Bag
Diltiazem Bag
Dobutamine Bag
Dobutamine syringe
Ephedrine syringes
Epinephrine Bag
Epinephrine Bag
Epinephrine syringe
Epoetin Alfa syringe
Esmolol syringes
Famotidine syringe
Fentanyl Citrate Bag
Fentanyl Citrate with Bupivacaine HCL Bag
Gentamicin syringe
Gentamicin Bag
Glycopyrrolate syringes
Granisetron syringe
Hectoral syringe
Heparin syringe
Heparin bag
Hydromorphone syringe
Hydromorphone Bag
Hydromorphone PCA syringe
LET Gel syringe
LET Soln syringe
Leukine syringe
Magnesium Sulfate bag
Meperidine Bag
Midazolam Bag
Midazolam syringe
Morphine Sulfate Bag
Morphine Sulfate syringe
Norepinephrine bag
Norepinephrine Syringe
Ondansetron Bag
Ondansetron syringe
Oxacillin syringe
Oxacillin Bag
Oxytocin bag
Palanosetron (Aloxi) syringe
Penicillin syringe
Penicillin Bag
Phenylephrine Bags
Phenylephrine syringes
Potassium Chloride Bag
Potassium Phosphate l bag
Ranitidine syringe
Rituxan syringe
Ropivacaine Bag
Ropivacaine OnQ Pump
Sodium Citrate syringe
Sodium Phosphate bag
Succinylcholine syringes
Sufentanil with Bupivacaine Bag
Timentin syringe
Tobramycin syringe
Zometa syringe
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources